DUBLIN, Calif., May 15 /PRNewswire-FirstCall/ -- SuperGen, Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer, is scheduled to present at the Citi Investment Research Global Healthcare Conference on May 22, 2008 at the Hilton Hotel in New York.
SuperGen's presentation at the Citi Investment Research Global Healthcare Conference is scheduled to begin at 3:00 p.m. EDT (12:00 p.m. PDT). A live webcast of the presentation will be available on the investor relations section of the Company's Web site at www.supergen.com. A webcast replay of the presentation will be available for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
CONTACT: Timothy L. Enns, SVP, Corporate Communications & Business
Development, +1-925-560-0100, tenns@supergen.com, Mary M. Vegh, Manager,
Investor Relations, +1-925-560-2845, mary.vegh@supergen.com, both of
SuperGen, Inc.
Web site: http://www.supergen.com/
